Experimental
C15 (Pentadecanoic Acid)
The prediction game
Call it: rising or fading?
Where does C15 (Pentadecanoic Acid) stand 12 months from now? Lock your call with a confidence level. When the window closes, the Brier rule scores your calibration: right and confident earns the most, wrong and confident costs the most. Points and a leaderboard spot are the whole prize. No stakes, no money.
One call per intervention. It locks the moment you submit: no edits, no cancels. It resolves when the 12-month window closes.
The Crowd’s Call
Rising or fading over the next 12 months? Lock your call and find out if you saw it coming.
Community Signal
No weigh-ins yet. Be the first and set the early signal.
Evidence
Evidence grade: E (thin evidence)
Graded from the strength of the published research, independent of any verdict on this page.
Evidence Anchor
BioHarmony 4.9/10
C15 (Pentadecanoic Acid) is a 4.9 / 10 fit for people using metabolic health, liver detox, and cardiovascular as a measured experiment, not a belief-based staple. The best anchors are [Sun et al. 2025](https://pubmed.ncbi.nlm.nih.gov/40987456/), which reports prospective and meta-analytic biomarker evidence and observational, not yet a C15:0 supplement trial, and [Steffen et al. 2026](https://www.frontiersin.org/journals/nutrition/articles/10.3389/fnut.2026.1720975/full), which reports cautionary cardiovascular evidence: modest observational associations, no incident CVD association, and no Mendelian-randomization support. That gives C15 (Pentadecanoic Acid) a real signal, but the report should stay narrow because responder fit, baseline status, and outcome tracking drive the practical value. Use C15 (Pentadecanoic Acid) when the target is specific, measurable, and worth the tradeoff. Skip or stop C15 (Pentadecanoic Acid) when the expected symptom, lab, or performance marker stays flat. ✅ Best for: Adults who do not eat dairy fat, follow vegan or low-dairy diets, have measured low circulating C15:0, and want a structured 12-week experiment rather than a belief-based subscription. C15:0 may also interest researchers replicating Robinson 2024 pharmacokinetic findings or clinicians studying diet-plus-C15 NAFLD protocols after TANGO. The cleanest use case is objective: baseline labs, 200 mg/day, repeat lipid panel and liver markers, then keep or stop based on measured change. ❌ Avoid if: You already consume grass-fed butter, aged cheese, full-fat yogurt, or other dairy fat and tolerate it well. Avoid C15:0 if pregnancy, lactation, pediatric use, or near-term conception is relevant, because Wang 2024 raises unresolved developmental questions. Skip it if your supplement budget is limited and omega-3, vitamin D3 + K2, fiber, sleep, resistance training, and fatty-liver diet basics are not handled. Do not use C15:0 as a substitute for guideline-backed cardiovascular, diabetes, liver, or cognitive care.
Read the full BioHarmony report
My score and my verdict: one signal of three, never the whole answer.
Momentum
Signals begin with Edition 2
Direction needs two weekly snapshots to compare, so the arrows stay off until the next edition. Attention tracking is already running.
Momentum = how fast attention is rising across search, Reddit, PubMed, podcasts, and curated industry newsletters this week; it can flag an item as Overhyped/Fading, but it never overrides the evidence behind Proven. How momentum works.
- Ring
- Experimental
- Trend
- Begins with Edition 2
- Momentum
- 0.0%
- BioHarmony Score
- 4.9/10
- Last Updated
- Jul 2, 2026
Sources
- BioHarmony score
- Search trend delta
- Reddit velocity
- PubMed publication count
- Podcast mention frequency
- Curated newsletter mentions
The score anchors the ring; the other five drive momentum, which can nudge the ring by one step at most. How placement works.
Weigh In
Your input feeds the community signal shown beside my verdict. It informs the board and it never sets the score by itself. How community input works.
New voice here? We send a one-tap verification link so every entry comes from a real person. Signed-in members skip this.